Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent metabolic disorder characterized by excessive hepatic fat accumulation. Intermittent fasting (IF) has emerged as a potential therapeutic strategy with the ability to induce weight loss, improve insulin sensitivity and reduce hepatic steatosis. We aim to compare the efficacy of different IF regimens for MASLD management. A systematic review and network meta-analysis of randomized controlled trials investigating different IF regimens for MASLD. PubMed, EMBASE, WOS, SCOPUS and Cochrane Central Register of Controlled Trials were searched until 10 April 2023. Analysis was performed using R software with the meta and netmeta packages. Mean difference (MD) was used to pool continuous outcomes with 95% confidence intervals (CIs). Our meta-analysis was registered in PROSPERO (CRD42023418467). Our meta-analysis included eight randomized controlled trials with a total of 635 participants. The 5 : 2 diet significantly improved liver stiffness (MD, −0.32; 95% CI, −0.55 to −0.09; P < 0.01). Time-restricted feeding significantly improved liver steatosis (controlled attenuation parameter score) (MD, −39.83; 95% CI, −64.78 to −14.87; P < 0.01). No significant changes were observed in asparate aminotransferase, gamma-glutamyl transpeptidase, low-density lipoproteins cholesterol, total cholesterol, triglyceride levels, basal metabolic index, blood pressure, Homeostatic Model Assessment of Insulin Resistance, fasting blood sugar, lean body mass or waist circumference across all IF regimens. However, alternate-day fasting showed positive results in anthropometric measures, including significant improvements in lean body mass, waist circumference, fat mass and weight reduction (P < 0.05). IF regimens showed various positive effects on clinical outcomes in MASLD patients; however, these effects were not consistent. Therefore, a patient-tailored IF regimen should be considered.

Overview

Integrity signals

Registry

Crossref · 10.1097/meg.0000000000002715

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

Metadata

Authors
Abuelazm, M. T., Mohamed, I., Naeem, A., Khlidj, Y., Tanashat, M., Katamesh, B. E., Abusuilik, H., Altobaishat, O., Abdelnabi, M., & Abdelazeem, B.
Affiliations
  • Tanta University (EG)
  • University of Missouri (US)
  • Al-Azhar University (EG)
  • Faculty of Medicine, University of Algiers, Algiers, Algeria
  • Yarmouk University (JO)
  • Mayo Clinic (US)
  • Faculty of Medicine, Hashemite University, Zarqa, Jordan
  • Jordan University of Science and Technology (JO)
  • University of Michigan (US)
  • West Virginia University (US)
Corresponding author
  • Abuelazm, Mohamed T.
  • Mohamed, Islam
Venue
European Journal of Gastroenterology & Hepatology
Published
2024-02-23
Volume
36
Issue
4
Pages
371-381
ISSN
0954-691X (ISSN-L)
OpenAlex
W4392166828
Cited by
21
References
35
Citations by year
2026: 6 · 2025: 11 · 2024: 4
FWCI
1.21
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
Keywords
intermittent fasting, non-alcoholic fatty liver disease, 5:2 diet, time-restricted feeding, alternate-day fasting, hepatic steatosis, liver stiffness, controlled attenuation parameter, weight loss, insulin resistance, anthropometric measures
MeSH terms
Network Meta-Analysis, Intermittent Fasting, Fatty Liver, Humans, Insulin Resistance, Cholesterol, LDL, Weight Loss, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1097/meg.0000000000002715
The paper
Abuelazm, M. T., Mohamed, I., Naeem, A., Khlidj, Y., Tanashat, M., Katamesh, B. E., Abusuilik, H., Altobaishat, O., Abdelnabi, M., & Abdelazeem, B. (2024). Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000002715

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.